%0 Journal Article
%T GSTM1 null genotype in COPD and lung cancer: evidence of a modifier or confounding effect?
%A Young RP
%A Hopkins RJ
%A Hay BA
%A Gamble GD
%J The Application of Clinical Genetics
%D 2011
%I Dove Medical Press
%R http://dx.doi.org/10.2147/TACG.S21517
%X ull genotype in COPD and lung cancer: evidence of a modifier or confounding effect? Original Research (2734) Total Article Views Authors: Young RP, Hopkins RJ, Hay BA, Gamble GD Published Date September 2011 Volume 2011:4 Pages 137 - 144 DOI: http://dx.doi.org/10.2147/TACG.S21517 Robert P Young1,2, Raewyn J Hopkins1, Bryan A Hay1, Gregory D Gamble1 1Schools of Biological Science and Health Sciences, University of Auckland, 2Department of Medicine, Auckland City Hospital, Auckland, New Zealand Background: Studies over the past two decades have reported associations between GSTM1 (glutathione S-transferase mu 1) null genotype and chronic obstructive pulmonary disease (COPD) or lung cancer. However, a modifier or confounding effect from COPD mediating the GSTM1 association with lung cancer has not been previously explored. Aim and methods: This variant was examined in a case-control study of current or former smokers with COPD (n = 669), lung cancer (n = 454), or normal lung function (n = 488). Sex, age, and smoking history were comparable between groups. Results: The GSTM1 null genotype was found to be more frequent in smokers with COPD alone (odds ratio [OR] 1.30, 95% confidence interval [CI] 1.02每1.66, P = 0.031) and lung cancer (OR 1.26, 95% CI 0.96每1.65, P = 0.083) than in matched smokers with normal lung function (62%, 61%, and 56%, respectively). However, when smokers with lung cancer were subgrouped according to the presence of COPD, then the association with all COPD subjects (OR 1.34, 95% CI 1.07每1.70, P = 0.010) and with COPD and lung cancer (OR 1.50, 95% CI 1.06每2.12, P = 0.018) continued to be significant while that with lung cancer only was reduced (OR 1.11, 95% CI 0.78每1.56, P = 0.55). These associations were independent of age, sex, height, lung function, and smoking history. Conclusion: Findings suggest that COPD is an important subphenotype of lung cancer and may underlie previously reported associations with the GSTM1 null genotype.
%K lung cancer
%K chronic obstructive pulmonary disease
%K GSTM1
%K association study
%K polymorphism
%K copy number variant
%U https://www.dovepress.com/gstm1-null-genotype-in-copd-and-lung-cancer-evidence-of-a-modifier-or--peer-reviewed-article-TACG